Combination ace inhibitors and angiotensin II receptor blockers for hypertensionFINNEGAN, Patrick M; GLEASON, Brenda L.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 886-889, issn 1060-0280, 4 p.Article

The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivativesAGELIS, George; RESVANI, Amalia; MATSOUKAS, John et al.European journal of medicinal chemistry. 2012, Vol 55, pp 358-374, issn 0223-5234, 17 p.Article

Angiotensin II receptor blockers for the treatment of heart failure : A class effect?HUDSON, Marie; HUMPHRIES, Karin; TU, Jack V et al.Pharmacotherapy. 2007, Vol 27, Num 4, pp 526-534, issn 0277-0008, 9 p.Article

Telmisartan reduces triglyceride levels over other angiotensin II receptor blocker: A meta-analysis of randomized head-to-head trialsTAKAGI, Hisato; UMEMOTO, Takuya.International journal of cardiology. 2012, Vol 157, Num 3, pp 403-407, issn 0167-5273, 5 p.Article

Choice of initial antihypertensive drugs and persistence of drug use: a 4-year follow-up of 78,453 incident usersSELMER, Randi; SALVESEN BLIX, Hege; LANDMARK, Knud et al.European journal of clinical pharmacology. 2012, Vol 68, Num 10, pp 1435-1442, issn 0031-6970, 8 p.Article

Targeting effective blood pressure control with angiotensin receptor blockersASMAR, R.International journal of clinical practice (Esher). 2006, Vol 60, Num 3, pp 315-320, issn 1368-5031, 6 p.Article

The role of angiotensin II receptor blockers in the management of heart failureMCMURRAY, John J. V.European heart journal supplements. 2005, Vol 7, Num J, pp J10-J14, issn 1520-765XArticle

Clinical evidence from ONTARGET: proven cardio- and vascular protectionTEO, Koon K.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F9-F15Conference Paper

Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditisXUEFEI LIU; XINGLEI ZHU; AIYING WANG et al.International journal of cardiology. 2009, Vol 137, Num 3, pp 282-288, issn 0167-5273, 7 p.Article

Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trialsVOLPE, Massimo; TOCCI, Giuliano; SCIARRETTA, Sebastiano et al.Journal of hypertension. 2009, Vol 27, Num 5, pp 941-946, issn 0263-6352, 6 p.Article

Involvement of Uric Acid Transporters in Alteration of Serum Uric Acid Level by Angiotensin II Receptor BlockersSATO, Masanobu; IWANAGA, Takashi; MAMADA, Hideaki et al.Pharmaceutical research. 2008, Vol 25, Num 3, pp 639-646, issn 0724-8741, 8 p.Article

Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs)ARANDA, P; VALDIVIELSO, P; PISCIOTTA, L et al.Clinical nephrology. 2008, Vol 69, Num 3, pp 213-218, issn 0301-0430, 6 p.Article

Current guidelines for treatment of heart failure : 2006 updateUDDIN, Nabil; PATTERSON, J. Herbert.Pharmacotherapy. 2007, Vol 27, Num 4, issn 0277-0008, 12S-17S, 2Article

Angiotensin-II receptor blockers : benefits beyond blood pressure reduction?VOLPE, M; RUILOPE, L. M; MCINNES, G. T et al.Journal of human hypertension. 2005, Vol 19, Num 5, pp 331-339, issn 0950-9240, 9 p.Article

Angiotensin II receptor blockers and myocardial infarction : deeds and misdeedsVOLPE, Massimo; MANCIA, Giuseppe; TRIMARCO, Bruno et al.Journal of hypertension. 2005, Vol 23, Num 12, pp 2113-2118, issn 0263-6352, 6 p.Article

Renin-angiotensin system modulation : The weight of evidenceBROWN, Ben; HALL, Alistair S.American journal of hypertension. 2005, Vol 18, Num 9, pp 127S-133S, issn 0895-7061, 2Conference Paper

Angiotensin II and inflammation : the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockadeDANDONA, P; DHINDSA, S; GHANIM, H et al.Journal of human hypertension. 2007, Vol 21, Num 1, pp 20-27, issn 0950-9240, 8 p.Article

Vascular protection: telmisartan in the ONTARGET Trial ProgrammeDAGENAIS, Gilles R.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F47-F53Conference Paper

The effects of replacing dihydropyridine calcium-channel blockers with angiotensin II receptor blocker on the quality of life of hypertensive patientsYAMAMOTO, Shigeki; KAWASHIMA, Takashi; KUNITAKE, Toshiaki et al.Blood pressure. 2003, Vol 12, pp 22-28, issn 0803-7051, 7 p., SUP2Article

Influence of Guidelines on Physicians' Assessment of Blood Pressure Lowering Effects and Achievement Rate of Blood Pressure Target During Transitional Period of GuidelinesKUSHIRO, Toshio; SAITO, Ikuo; SATO, Yuki et al.Clinical and experimental hypertension (1993). 2009, Vol 31, Num 2, pp 116-126, issn 1064-1963, 11 p.Article

Effects of Angiotensin II Receptor Blockers on Relationships Between 24-Hour Blood Pressure, Autonomic Function, and Health-Related QOLOKANO, Yasuko; TAMURA, Kouichi; KUJI, Tadashi et al.Clinical and experimental hypertension (1993). 2009, Vol 31, Num 3, pp 250-258, issn 1064-1963, 9 p.Conference Paper

The rationale for choosing telmisartan and ramipril in the ONTARGET programmeUNGER, Thomas.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F3-F8Conference Paper

Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patientsFURUYA, Ryuichi; ODAMAKI, Mari; KUMAGAI, Hiromichi et al.Blood purification. 2006, Vol 24, Num 5-6, pp 445-450, issn 0253-5068, 6 p.Article

Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatmentWILLEMSEN, J. M; RABELINK, T. J; BOER, P et al.Journal of human hypertension. 2004, Vol 18, Num 12, pp 857-863, issn 0950-9240, 7 p.Article

The effect of recombinant aminopeptidase A (APA) on hypertension in pregnant spontaneously hypertensive rats (SHRs)ISHII, Masakazu; HATTORI, Akira; NUMAGUCHI, Yasushi et al.Early human development. 2009, Vol 85, Num 9, pp 589-594, issn 0378-3782, 6 p.Article